News & Press Releases

NEWS RELEASE

FOR IMMEDIATE RELEASE: August 26, 2010

FOR INFORMATION: Therese Clay, XO Marketing Group, (801)541-9244

e-mail therese@xomktg.com

LIFETREE CLINICAL RESEARCH® TO PARICIPATE AT 13th WORLD CONGRESS ON PAIN

Salt Lake City-Lifetree Clinical Research® and Lifetree Center for Neuroscience Research, one of the largest specialized clinical research organizations in the Western region of the United States, will participate as an exhibitor at the 13^th World Congress on Pain Aug. 29 through Sept. 6 in Montréal, Québec, Canada. Lifetree chief medical director and lead investigator, Lynn R. Webster, M.D., will also present a poster and participate in two symposiums.

"We are looking forward to participating in the World Congress on Pain. It is the world’s largest pain-related gathering, and it will be a great arena for Lifetree to introduce our specialized services to an international audience,” said Lifetree Clinical Research CEO Alice Jackson. "Since 2003, Lifetree has steadfastly promoted the growing need for better pain-management solutions. The World Congress on Pain provides a perfect platform for us to work with our peers and clients in developing solutions for pain relief throughout the world. Dr. Webster is highly respected and a published thought leader in pain and abuse liability, and his presentations will provide great insight to interdisciplinary leaders.”

Webster’s clinical research projects at Lifetree have produced important results on pain and pain mechanisms, substance abuse, addiction and the use of chronic pain medication and the impact these medications have on sleep. He will participate in discussions at the World Congress on Pain regarding how to safely and appropriately prescribe opioids, which requires the assessment of patients for the risk of misuse or abuse of opioids. Thought leaders will review common screening tools, their strengths and weaknesses and how to properly administer them in a busy practice. The discussion will close with suggestions on how to best manage the risks and aberrant behaviors assessed with the tools. He will also participate in a detailed review of the clinical data supporting the efficacy and safety of dual-opioid therapy in acute pain.

The World Congress on Pain is a biennial gathering presented by the International Association for the Study of Pain (IASP), a leading professional forum for science, practice and education in the field of pain. Attendees are invited to stop by the Lifetree booth number 817 to meet the Lifetree management team and learn about the company’s specialized services. Lifetree Clinical Research® now provides a broader range of central nervous system-related investigations with the formation of Lifetree Center for Neuroscience Research in April 2008. The company also provides experimental drug development expertise for clients utilizing three human experimental pain models to assess the efficacy of new analgesic drugs: Cold Pressor, Neurometer®/QST, and Heat/Capsaicin.

ABOUT LIFETREE CLINICAL RESEARCH®:

Lifetree Clinical Research® offers multi-therapeutic clinical trials management (CTM) and site expertise in phase I-III clinical trials, with a unique approach to phase I, abuse liability, central nervous system and analgesia. Lifetree Clinical Research® is strategically integrated with Lifetree Pain Clinic in a seamless 25,000-square-foot, 60-bed facility and offers advanced expertise in first-in-human/MTD, bioavailability and bioequivalence, PK/PD/proof of concept, innovative pain model development and Cerebral Spinal Fluid sampling. Site services include PET Scanning, MRS and FMRI Capabilities and on-site pharmacy capable of handling all scheduled drugs I –V. For more detailed information about Lifetree Clinical Research®, please visit www.lifetreeresearch.com.